Valproate in pregnancy: comment from the SAPP: Comment on: Use of valproate in pregnancy and in women of childbearing age between 2014 and 2018 in Switzerland: a retrospective analysis of Swiss healthcare claims data. Swiss Med Wkly. 2021;151:w20386 (original) (raw)

Skip to main navigation menu Skip to main content Skip to site footer

Technical comment

Vol. 151 No. 0708 (2021)

References

  1. Spoendlin J, Blozik E, Graber S, Rauch M, Marxer C, Rüegg S, et al. Use of valproate in pregnancy and in women of childbearing age between 2014 and 2018 in Switzerland: a retrospective analysis of Swiss healthcare claims data. Swiss Med Wkly. 2021;151:w20386.
  2. Toledo M, Mostacci B, Bosak M, Jedrzejzak J, Thomas RH, Salas-Puig J, et al. Expert opinion: use of valproate in girls and women of childbearing potential with epilepsy: recommendations and alternatives based on a review of the literature and clinical experience-a European perspective. J Neurol. 2020. doi:.https://doi.org/10.1007/s00415-020-09809-0
  3. Tomson T, Battino D, Bonizzoni E, Craig J, Lindhout D, Perucca E, et al.; EURAP Study Group. Declining malformation rates with changed antiepileptic drug prescribing: An observational study. Neurology. 2019;93(9):e831–40. doi:.https://doi.org/10.1212/WNL.0000000000008001
  4. Daugaard CA, Sun Y, Dreier JW, Christensen J. Use of antiepileptic drugs in women of fertile age. Dan Med J. 2019;66(8):1–5.
  5. Andrade C. Valproate in Pregnancy: Recent Research and Regulatory Responses. J Clin Psychiatry. 2018;79(3):18f12351. doi:.https://doi.org/10.4088/JCP.18f12351
  6. Neilson JP. Ultrasound for fetal assessment in early pregnancy. Cochrane Database Syst Rev. 2000;(2):CD000182.
  7. May TW, Pfäfflin M, Coban I, Schmitz B. Frauen mit Epilepsie: Befürchtungen, Wissen, Beratungsbedarf. Ergebnisse einer Querschnittstudie bei Patientinnen in ambulanter Behandlung [Fears, knowledge, and need of counseling for women with epilepsy. Results of an outpatient study]. Nervenarzt. 2009;80(2):174–83. doi:.https://doi.org/10.1007/s00115-008-2632-x
  8. Broeks SC, Thisted Horsdal H, Glejsted Ingstrup K, Gasse C. Psychopharmacological drug utilization patterns in pregnant women with bipolar disorder - A nationwide register-based study. J Affect Disord. 2017;210:158–65. doi:.https://doi.org/10.1016/j.jad.2016.12.001
  9. Tomson T, Battino D, Bonizzoni E, Craig J, Lindhout D, Perucca E, et al.; EURAP Study Group. Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry. Lancet Neurol. 2018;17(6):530–8. doi:.https://doi.org/10.1016/S1474-4422(18)30107-8
  10. Federal Act of 30 September 2011 on Research involving Human Beings (Human Research Act, HRA). https://www.fedlex.admin.ch/eli/cc/2013/617/en
  11. Wettach C, Thomann J, Lambrigger-Steiner C, Buclin T, Desmeules J, von Mandach U. Pharmacovigilance in pregnancy: adverse drug reactions associated with fetal disorders. J Perinat Med. 2013;41(3):301–7. doi:.https://doi.org/10.1515/jpm-2012-0091
  12. EURAP. An International Antiepileptic Drugs and Pregnancy Registry. Interim Report – November 2020. Available from: https://eurapinternational.org/wp-content/uploads/2020/12/EurapReport_Nov2020.pdf
  13. Schenkel L, Simões-Wüst AP, Hösli I, von Mandach U. Medikamente in Schwangerschaft und Stillzeit – In den Schweizer Perinatalzentren verwendete Medikamente [Drugs in Pregnancy and Lactation - Medications Used in Swiss Obstetrics]. Z Geburtshilfe Neonatol. 2018;222(04):152–65. doi:.https://doi.org/10.1055/s-0043-124975
  14. AmiKoWeb. https://amiko.oddb.org/de/fulltext?id=80dfeafcda&key=SAPP
  15. Swiss Database for Dosing Medicinal Products in Pediatrics (SwissPedDose). https://www.swisspeddose.ch

Most read articles by the same author(s)